Publications

Publications

Filter Results: (610) Arrow Down
Filter Results: (610) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 29 of 610 Results →
  • 12 Jan 2016
  • First Look

January 12, 2016

November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
  • 23 May 2017
  • First Look

First Look at New Ideas and Research: May 23, 2017

of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into 16... View Details
Keywords: Carmen Nobel
  • 18 Aug 2011
  • Lessons from the Classroom

Business Plan Contest: 15 Years of Building Better Entrepreneurs

impact on our trajectory." Last year, with three remaining locations in the Boston area, Finale's original lead investors acquired a majority ownership in the business, folding it into a Rhode Island-based holding company where Conforti... View Details
Keywords: by Julia Hanna; Education
  • 01 Jun 2011
  • News

The Best-Laid Plans

Finale’s original lead investors acquired a majority ownership in the business, folding it into a Rhode Island–based holding company where Conforti now serves as managing partner of the restaurant group. “When I started Finale, I... View Details
Keywords: Julia Hanna; contests; Health, Social Assistance; Architectural, Engineering, and Related Services; Professional Services; Management, Scientific, and Technical Consulting Services; Professional Services
  • 05 Aug 2008
  • First Look

First Look: August 5, 2008

/b01/en/common/item_detail.jhtml?id=808167 The Coartem Challenge (A) Harvard Business School Case 706-037 In November 2005, Novartis, a major global pharmaceutical firm, is reviewing its Coartem program, an ambitious attempt to deliver... View Details
Keywords: Martha Lagace
  • 12 Oct 2006
  • First Look

First Look: October 12, 2006

Protection Agency (US EPA) program that encourages companies to self-disclose violations of environmental laws and regulations in exchange for reduced sanctions. We find that facilities are more likely to self-disclose if they were... View Details
Keywords: Sean Silverthorne
  • 05 May 2023
  • News

Fail Better

Chairman, CEO, and Cofounder Steve Schwarzman (MBA 1972). In 1989, a few years after Blackstone's start, Schwarzman made the unfortunate decision to purchase steel company Edgcomb and was called on the carpet by one of the fund's major... View Details
  • 20 Feb 2018
  • First Look

First Look at New Research and Ideas, February 20, 2018

new fund. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317036-PDF-ENG Harvard Business School Case 118-052 Charity or Bribery? Filip Kowalski, a senior manager at the pharmaceutical company... View Details
Keywords: Sean Silverthorne
  • 03 Jan 2017
  • First Look

January 3, 2017

silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For new precision therapies to be developed, these data sets need to be shared broadly. Patients can help lead this effort by... View Details
Keywords: Carmen Nobel
  • 28 May 2008
  • First Look

First Look: May 28, 2008

goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding... View Details
Keywords: Martha Lagace
  • 02 Apr 2013
  • First Look

First Look: April 2

care needs to go "beyond the pill" and systematically integrate combinations of treatments. We discuss the implications of this approach for organizational and business models in the pharmaceutical industry. 2006 World Politics... View Details
Keywords: Sean Silverthorne
  • 12 Jan 2010
  • First Look

First Look: Jan. 12

and illustrates, via a detailed description of the successful strategic alliance between Solvay Pharmaceuticals Inc. and Quintiles company how the creation of a strategy map and Balanced Scorecard helps... View Details
Keywords: Martha Lagace
  • 09 Jan 2007
  • First Look

First Look: January 9, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441  ... View Details
Keywords: Martha Lagace
  • 01 Apr 2000
  • News

Getting the Message

Sponsorships allow advertisers to offer content that is related to their products or services and valued by the target audience. For example, a pharmaceutical company might sponsor a bulletin board for... View Details
Keywords: Susan Young
  • 24 Apr 2018
  • First Look

First Look at New Research and Ideas, April 24, 2018

Bird, Yanhua Z., Jodi L. Short, and Michael W. Toffel Abstract—Exploitive working conditions have spurred companies to pressure their suppliers to adopt labor codes of conduct and to conform their labor practices to the standards set... View Details
Keywords: Sean Silverthorne
  • 10 Jan 2005
  • Research & Ideas

Motivation and the Cross-Sector Alliance

The first question focuses on motivations, while the second one has more to do with the benefits sought in interactions with future partners. Altruism As a general rule, collaboration efforts between companies and CSOs have an inherent... View Details
Keywords: by James Austin, Ezequiel Reficco & SEKN research team
  • 26 Apr 2011
  • Op-Ed

HBS Faculty Comment on Environmental Issues for Earth Day

have been experimenting with integrated project delivery—a collaborative process that involves unprecedented teamwork and shared decision making throughout a design and building project. A number of companies are developing... View Details
Keywords: by Staff; Energy; Utilities
  • 05 Sep 2007
  • First Look

First Look: September 5, 2007

value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise... View Details
Keywords: Martha Lagace
  • 03 Sep 2013
  • First Look

First Look: September 3

results. Purchase this case: http://hbr.org/search/713537-PDF-ENG Harvard Business School Case 814-014 Sample6: Innovating to Make Food Safer Tim Curran, CEO of Sample6, a start-up biotechnology company developing a novel food safety... View Details
Keywords: Sean Silverthorne
  • 18 Dec 2012
  • First Look

First Look: December 18

pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access... View Details
Keywords: Carmen Nobel